Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Entecavir vs Adefovir in Decompensated Chronic Hepatitis B
NCT00065507Phase 3Completed
- Sponsor
- Bristol Myers Squibb
- Start
- Aug 2003
- Primary completion
- Oct 2008
- Modality
- Small Molecules
- Countries
- 17
01
Overview
A Phase 3 trial of entecavir in Chronic Hepatitis B (CHB), sponsored by Bristol Myers Squibb. Started Aug 2003; status: completed.
02
Drugs
entecavir
03
Conditions
Chronic Hepatitis B (CHB)
Beyond the preview
Go deeper on NCT00065507.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00065507.